-
1
-
-
58149296156
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
-
EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatol 2009; 50: 227-42.
-
(2009)
J Hepatol
, vol.50
, pp. 227-242
-
-
-
2
-
-
1642410856
-
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
-
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepatitis 2004; 11: 97-107.
-
(2004)
J. Viral Hepatitis
, vol.11
, pp. 97-107
-
-
Lavanchy, D.1
-
3
-
-
24344468256
-
Prevention and surveillance of hepatitis B virusrelated hepatocellular carcinoma
-
Liaw YF. Prevention and surveillance of hepatitis B virusrelated hepatocellular carcinoma. Semin Liver Dis 2005; 25: 40-7.
-
(2005)
Semin Liver Dis
, vol.25
, pp. 40-47
-
-
Liaw, Y.F.1
-
4
-
-
33646368376
-
Hepatitis B virus-related cirrhosis: Natural history and treatment
-
Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis 2006; 26: 142-52.
-
(2006)
Semin Liver Dis
, vol.26
, pp. 142-152
-
-
Chu, C.M.1
Liaw, Y.F.2
-
5
-
-
0037330951
-
Epidemiology and prevention of Hepatitis B
-
Alter MJ. Epidemiology and prevention of Hepatitis B. Semin Liver Dis 2003; 23: 39-46.
-
(2003)
Semin Liver Dis
, vol.23
, pp. 39-46
-
-
Alter, M.J.1
-
6
-
-
77955401739
-
A survey of chronic hepatitis B patient management practices in the European Union
-
Berg T, Benhamou Y, Calleja JL, Levrero M, Johnson W, Ellis N. A survey of chronic hepatitis B patient management practices in the European Union. J Viral Hepatitis 2010; 17: 624-30.
-
(2010)
J Viral Hepatitis
, vol.17
, pp. 624-630
-
-
Berg, T.1
Benhamou, Y.2
Calleja, J.L.3
Levrero, M.4
Johnson, W.5
Ellis, N.6
-
7
-
-
77956639159
-
Long-Term Entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
-
Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, Safadi R, et al. Long-Term Entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010; 52: 886-93.
-
(2010)
Hepatology
, vol.52
, pp. 886-893
-
-
Chang, T.T.1
Liaw, Y.F.2
Wu, S.S.3
Schiff, E.4
Han, K.H.5
Lai, C.L.6
Safadi, R.7
-
8
-
-
79951684909
-
Long-term treatment with Entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B
-
Schiff ER, Lee SS, Chao YC, Yoon SK, Bessone F, Wu SS, Kryczka W, et al. Long-term treatment with Entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B. Clin Gastro Hepatol 2011; 9: 274-6.
-
(2011)
Clin Gastro Hepatol
, vol.9
, pp. 274-276
-
-
Schiff, E.R.1
Lee, S.S.2
Chao, Y.C.3
Yoon, S.K.4
Bessone, F.5
Wu, S.S.6
Kryczka, W.7
-
9
-
-
84892697549
-
Five years of treatment with Tenofovir DF (TDF) for chronic hepatitis B (CHB) infection in Asian patients is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis
-
Gane EJ, Marcellin P, Sievert W, Trinh HN, Shiffman ML, Washington M, Barnes CN, et al. Five years of treatment with Tenofovir DF (TDF) for chronic hepatitis B (CHB) infection in Asian patients is associated with sustained viral suppression and significant regression of histological fibrosis and cirrhosis. Hepatology 2011; 54(Suppl. 1): A1429.
-
(2011)
Hepatology
, vol.54
, Issue.SUPPL. 1
-
-
Gane, E.J.1
Marcellin, P.2
Sievert, W.3
Trinh, H.N.4
Shiffman, M.L.5
Washington, M.6
Barnes, C.N.7
-
10
-
-
70349240414
-
Chronic hepatitis B: Update 2009
-
Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 1-36.
-
(2009)
Hepatology
, vol.50
, pp. 1-36
-
-
Lok, A.S.F.1
McMahon, B.J.2
-
11
-
-
51049107683
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
-
for the Chronic Hepatitis B Guideline Workshop Party of the Asian-Pacific Association for the Study of the Liver
-
Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, et al., for the Chronic Hepatitis B Guideline Workshop Party of the Asian-Pacific Association for the Study of the Liver. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-83.
-
(2008)
Hepatol Int
, vol.2
, pp. 263-283
-
-
Liaw, Y.F.1
Leung, N.2
Kao, J.H.3
Piratvisuth, T.4
Gane, E.5
Han, K.H.6
Guan, R.7
-
12
-
-
75449102162
-
Entecavir in decompensated HBV cirrhosis: The future is looking brighter
-
Fontana RJ. Entecavir in decompensated HBV cirrhosis: The future is looking brighter. J Hepatol 2010; 52: 147-9.
-
(2010)
J Hepatol
, vol.52
, pp. 147-149
-
-
Fontana, R.J.1
-
13
-
-
0035146422
-
A model to predict survival in patients with end-stage liver disease
-
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
-
(2001)
Hepatology
, vol.33
, pp. 464-470
-
-
Kamath, P.S.1
Wiesner, R.H.2
Malinchoc, M.3
Kremers, W.4
Therneau, T.M.5
Kosberg, C.L.6
D'Amico, G.7
-
15
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
-
(2005)
Hepatology
, vol.42
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
16
-
-
0037232566
-
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus related cirrhosis
-
Hann HW, Fontana RJ, Wright T, Everson G, Baker A, Schiff ER, Riely C, et al. A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus related cirrhosis. Liver Transpl 2003; 9: 49-56.
-
(2003)
Liver Transpl
, vol.9
, pp. 49-56
-
-
Hann, H.W.1
Fontana, R.J.2
Wright, T.3
Everson, G.4
Baker, A.5
Schiff, E.R.6
Riely, C.7
-
17
-
-
33947427581
-
Adefovir dipivoxil for wait-listed and post-liver transplantationpatients with lamivudine-resistant hepatitis B: Final long-term results
-
Schiff E, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann H, et al. Adefovir dipivoxil for wait-listed and post-liver transplantationpatients with lamivudine-resistant hepatitis B: final long-term results. Liver Transpl 2007; 13: 349-60.
-
(2007)
Liver Transpl
, vol.13
, pp. 349-360
-
-
Schiff, E.1
Lai, C.L.2
Hadziyannis, S.3
Neuhaus, P.4
Terrault, N.5
Colombo, M.6
Tillmann, H.7
-
18
-
-
79954534132
-
Treatment of decompensated HBV-cirrhosis: Results from 2-years randomized trial with telbivudine or lamivudine
-
Gane EJ, Chan HL, Choudhuri G, Suh DJ, Chutaputti A, Safadi R, Tanwandee T, et al. Treatment of decompensated HBV-cirrhosis: results from 2-years randomized trial with telbivudine or lamivudine. J Hepatol 2010; 52(Suppl. 1): S4.
-
(2010)
J Hepatol
, vol.52
, Issue.SUPPL. 1
-
-
Gane, E.J.1
Chan, H.L.2
Choudhuri, G.3
Suh, D.J.4
Chutaputti, A.5
Safadi, R.6
Tanwandee, T.7
-
19
-
-
0033929544
-
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
-
Yao FY, Bass NM. Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection. J Hepatol 2000; 33: 301-7.
-
(2000)
J Hepatol
, vol.33
, pp. 301-307
-
-
Yao, F.Y.1
Bass, N.M.2
-
20
-
-
0033931789
-
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis
-
Kapoor D, Guptan RC, Wakil SM, Kazim SN, Kaul R, Agarwal SR, Raisuddin S, et al. Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol 2000; 33: 308-12.
-
(2000)
J Hepatol
, vol.33
, pp. 308-312
-
-
Kapoor, D.1
Guptan, R.C.2
Wakil, S.M.3
Kazim, S.N.4
Kaul, R.5
Agarwal, S.R.6
Raisuddin, S.7
-
21
-
-
17544369393
-
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
-
Villeneuve JP, Condreay LD, Willems B, Pomier-Layrargues G, Fenyves D, Bilodeau M, Leduc R, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B. Hepatology 2000; 31: 207-10.
-
(2000)
Hepatology
, vol.31
, pp. 207-210
-
-
Villeneuve, J.P.1
Condreay, L.D.2
Willems, B.3
Pomier-Layrargues, G.4
Fenyves, D.5
Bilodeau, M.6
Leduc, R.7
-
22
-
-
0034927065
-
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort
-
Yao FY, Terrault NA, Freise C, Maslow L, Bass NM. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology 2001; 34: 411-6.
-
(2001)
Hepatology
, vol.34
, pp. 411-416
-
-
Yao, F.Y.1
Terrault, N.A.2
Freise, C.3
Maslow, L.4
Bass, N.M.5
-
23
-
-
19544391413
-
Lamivudine for patients with chronic hepatitis B and advanced liver disease
-
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-31.
-
(2004)
N Engl J Med
, vol.351
, pp. 1521-1531
-
-
Liaw, Y.F.1
Sung, J.J.2
Chow, W.C.3
Farrell, G.4
Lee, C.Z.5
Yuen, H.6
Tanwandee, T.7
-
24
-
-
75349107764
-
Efficacy of entecavir in treatment-naïve decompensated cirrhosis
-
Shim JH, Lee HC, Ki KM, Kim Y-S, Chung Y-H, Lee YS, Suh DJ. Efficacy of entecavir in treatment-naïve decompensated cirrhosis. J Hepatol 2010; 52: 176-82.
-
(2010)
J Hepatol
, vol.52
, pp. 176-182
-
-
Shim, J.H.1
Lee, H.C.2
Ki, K.M.3
Kim, Y.-S.4
Chung, Y.-H.5
Lee, Y.S.6
Suh, D.J.7
-
25
-
-
79959551969
-
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, openlabel study
-
Liaw YF, Raptopoulou-Gigi M, Cheinquer H, Sarin SK, Tanwandee T, Leung N, Peng CY, et al. Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, openlabel study. Hepatology 2011; 54: 91-100.
-
(2011)
Hepatology
, vol.54
, pp. 91-100
-
-
Liaw, Y.F.1
Raptopoulou-Gigi, M.2
Cheinquer, H.3
Sarin, S.K.4
Tanwandee, T.5
Leung, N.6
Peng, C.Y.7
-
26
-
-
84858295076
-
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis
-
Hyun JJ, Seo YS, Yoon E, Kim TH, Kim DJ, Kang HS, Jung ES, et al. Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis. Liver Int 2012; 32: 656-64.
-
(2012)
Liver Int
, vol.32
, pp. 656-664
-
-
Hyun, J.J.1
Seo, Y.S.2
Yoon, E.3
Kim, T.H.4
Kim, D.J.5
Kang, H.S.6
Jung, E.S.7
-
27
-
-
78751491184
-
Tenofovir disoproxil fumarate (TDF), Emtricitabine/TDF, and Entecavir in patients with decompensated chronic hepatitis B liver disease
-
Liaw YF, Sheen IS, Lee CM, Akarca US, Papatheodoridis GV, Wong FS-H, Chang TT, et al. Tenofovir disoproxil fumarate (TDF), Emtricitabine/TDF, and Entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology 2011; 53: 62-72.
-
(2011)
Hepatology
, vol.53
, pp. 62-72
-
-
Liaw, Y.F.1
Sheen, I.S.2
Lee, C.M.3
Akarca, U.S.4
Papatheodoridis, G.V.5
Wong, F.S.-H.6
Chang, T.T.7
-
28
-
-
28844490547
-
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
-
D'Amico G, Gasrcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol 2006; 44: 217-31.
-
(2006)
J Hepatol
, vol.44
, pp. 217-231
-
-
D'Amico, G.1
Gasrcia-Tsao, G.2
Pagliaro, L.3
-
29
-
-
77950618947
-
Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis
-
Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 2010; 51: 1445-9.
-
(2010)
Hepatology
, vol.51
, pp. 1445-1449
-
-
Garcia-Tsao, G.1
Friedman, S.2
Iredale, J.3
Pinzani, M.4
-
30
-
-
0036730506
-
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
-
Fontana RJ, Hann H-WL, Perrillo RP, Vierling JM, Wright T, Rakela J, Anschuetz G, et al. Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy. Gastroenterology 2002; 123: 719-27.
-
(2002)
Gastroenterology
, vol.123
, pp. 719-727
-
-
Fontana, R.J.1
Hann, H.-W.L.2
Perrillo, R.P.3
Vierling, J.M.4
Wright, T.5
Rakela, J.6
Anschuetz, G.7
-
31
-
-
73149085984
-
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
-
Lange CM, Bojunga J, Hoffmann WP, Wunder K, Mihm U, Zeuzem S, Sarrazi C. Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function. Hepatology 2009; 50: 2001-9.
-
(2009)
Hepatology
, vol.50
, pp. 2001-2009
-
-
Lange, C.M.1
Bojunga, J.2
Hoffmann, W.P.3
Wunder, K.4
Mihm, U.5
Zeuzem, S.6
Sarrazi, C.7
|